FcgammaRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis.
about
Bin2 is a membrane sculpting N-BAR protein that influences leucocyte podosomes, motility and phagocytosis.Modulation of the lung inflammatory response to serotype 8 pneumococcal infection by a human immunoglobulin m monoclonal antibody to serotype 8 capsular polysaccharide.Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functionsMonoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterizationPSGL-1 on Leukocytes is a Critical Component of the Host Immune Response against Invasive Pneumococcal DiseaseFcγ Receptors in Solid Organ TransplantationA transcriptomic reporter assay employing neutrophils to measure immunogenic activity of septic patients' plasmaEffect of immune serum and role of individual Fcgamma receptors on the intracellular distribution and survival of Salmonella enterica serovar Typhimurium in murine macrophagesA Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosisThe biological significance of evolution in autoimmune phenomenaFcγRIIB and autoimmunity.Association of Fcγ receptor IIB polymorphism with cryptococcal meningitis in HIV-uninfected Chinese patientsSerum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae.Successful downstream application of the Paxgene Blood RNA system from small blood samples in paediatric patients for quantitative PCR analysis.Regulatory T cell-mediated resolution of lung injury: identification of potential target genes via expression profiling.A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosusSepticaemia models using Streptococcus pneumoniae and Listeria monocytogenes: understanding the role of complement properdin.Antibodies to the iron uptake ABC transporter lipoproteins PiaA and PiuA promote opsonophagocytosis of Streptococcus pneumoniae.Defunctioning polymorphism in the immunoglobulin G inhibitory receptor (FcγRIIB-T/T232) does not impact on kidney transplant or recipient survival.The efficacy of pneumococcal capsular polysaccharide-specific antibodies to serotype 3 Streptococcus pneumoniae requires macrophages.PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsisFcγRIIb inhibits immune complex-induced VEGF-A production and intranodal lymphangiogenesisEffect of fluconazole on phagocytic response of polymorphonuclear leukocytes in a rat model of acute sepsis.Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection.Hypoxia selectively inhibits respiratory burst activity and killing of Staphylococcus aureus in human neutrophils.Downmodulation of vaccine-induced immunity and protection against the intracellular bacterium Francisella tularensis by the inhibitory receptor FcγRIIB.Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria.Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.A serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibody requires Fcγ receptor III and macrophages to mediate protection against pneumococcal pneumonia in mice.FcγRIIb and BAFF differentially regulate peritoneal B1 cell survival.SIGN-R1 contributes to protection against lethal pneumococcal infection in mice.Analysis of a wild mouse promoter variant reveals a novel role for FcγRIIb in the control of the germinal center and autoimmunity.FcgammaRIII is protective against Pseudomonas aeruginosa pneumoniaFcgamma receptor regulation of Citrobacter rodentium infection.Regulation of allograft survival by inhibitory FcγRIIb signalingThe utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment.Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathwayLipopolysaccharide-Induced CD300b Receptor Binding to Toll-like Receptor 4 Alters Signaling to Drive Cytokine Responses that Enhance Septic ShockDifferential signal transduction, membrane trafficking, and immune effector functions mediated by FcgammaRI versus FcgammaRIIaEfficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice.
P2860
Q24307616-C13A1878-6C1D-4C7F-B88E-32E85F1FDEBDQ24532019-58BCA5F9-9247-479B-B31F-F5E4C594E201Q24532135-F8096CD7-0A21-47A3-960F-B8996F2A0AB9Q24655389-54F29926-5947-4CBD-9604-31C4C415C508Q27315060-33CD949B-C1DF-416E-BF27-7D889C21E674Q28076012-FACC1848-AE31-4A3E-9BE5-74B7AC092EAAQ28385146-F9EC5449-A76A-4BD2-942D-803586720AEAQ28510015-E00BCBE0-BED9-4C16-ACC1-017C041B16C7Q28591997-FA38F4AD-8839-4D79-9FA9-CDBCDD5BF7E9Q28730944-A9F79425-98A7-4DE4-8AFD-D9110198979CQ30981881-8E635FCE-A98A-4583-B78D-D166026F0CC2Q31083477-E0774B68-DA41-4B3C-93FC-FA75A298BD94Q33298405-9BE9ED1D-B60D-47A4-AC95-0EB7B61A3B8AQ33298669-AF143A05-056E-4DFB-AE5F-053D01DD4483Q33786454-061BD587-18FA-4E96-9D7E-F1C6ECCCC22CQ33842644-013D4B00-E78B-4972-B299-DDB2F6B8E178Q33984976-C6EC38E4-82BC-4A99-99FE-43FEE16CED09Q34033151-E7337E27-8C5F-4476-A27A-7073769FCA97Q34106643-F9CE2954-63B3-49F4-A974-550BA3867486Q34238386-36AAF20F-F82F-4863-A059-3A0B3A78D890Q34605998-29EFC9AC-25A4-41DA-8BE0-81768C48D3BCQ34752151-29EF23FF-2024-4B3D-ACCA-07DAEFC7D37CQ34803316-D0890FEB-95FB-4D7E-BC1A-418E08EBBA0EQ35133990-067523D9-481B-4F2A-B5A7-60CA356D9D6FQ35219730-700823C9-9735-42C2-989F-B7A3EA4E0EB5Q35563406-0E2FA1B5-A7DC-4BCE-84D3-371343839DF1Q35758478-FFE8B703-3E92-491D-A660-CFB9D6EBCA71Q35805480-BB34E810-4EFD-436E-90D9-81DCF5D7B6FBQ35867546-9CED2B9B-2442-475B-AEB4-063915F28B0CQ35991862-8E52A252-D199-46BC-911F-5E4EA7B758E8Q36399613-B4A6F1D2-ADFD-466F-8BCF-A32FC774F2C2Q36409027-3B0975F3-FCDC-43BC-A1AB-E12BE74105AEQ36508708-0EB120D9-8202-4A7E-A6F5-35DE08E8A4E5Q36539656-097A06A0-2F57-485B-B86D-D97C95E5EEB5Q36708983-28DB96B5-531D-4535-A40B-818549B7BD14Q36785777-DBF938AE-B702-46D9-8047-7188FF2BBDEFQ36804267-178CD646-C47C-4412-BE58-9D81153268C5Q37029724-282BB1C5-D8C4-4558-A244-E0A0A40AF80AQ37078202-F5DF591C-74A9-4965-A937-6D498E17E2A4Q37145037-33C322FA-8E96-419E-AF1D-044B9D5466FA
P2860
FcgammaRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
FcgammaRIIb balances efficient ...... diated consequences of sepsis.
@ast
FcgammaRIIb balances efficient ...... diated consequences of sepsis.
@en
type
label
FcgammaRIIb balances efficient ...... diated consequences of sepsis.
@ast
FcgammaRIIb balances efficient ...... diated consequences of sepsis.
@en
prefLabel
FcgammaRIIb balances efficient ...... diated consequences of sepsis.
@ast
FcgammaRIIb balances efficient ...... diated consequences of sepsis.
@en
P2860
P356
P1476
FcgammaRIIb balances efficient ...... ediated consequences of sepsis
@en
P2093
Menna R Clatworthy
P2860
P304
P356
10.1084/JEM.20032197
P407
P50
P577
2004-02-23T00:00:00Z